Research sheds light on treatment interruption.
Although there still is no clear answer about using structured treatment interruption as a therapeutic method with HIV patients, the strategy is gaining more respect as researchers from around the world continue to study it. Intermittent therapy, in which patients stop their antiretroviral therapy and then resume therapy in a cyclic way, may prove feasible, says one expert who spoke about interrupted treatment at the First International AIDS Society Conference on HIV Pathogenesis and Treatment in Buenos Aires, Argentina.
Fauci
A
A
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D019562:Viral Load
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors